End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
37,100 KRW | 0.00% |
|
-3.13% | -4.87% |
Business Summary
Number of employees: 18
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
BNF
100.0
%
| 30,726 | 100.0 % | 31,721 | 100.0 % | +3.24% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
100.0
%
| 30,726 | 100.0 % | 31,721 | 100.0 % | +3.24% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Dong-Hyun Park
FOU | Founder | 67 | 02-09-24 |
James Yeager
CTO | Chief Tech/Sci/R&D Officer | 78 | 04-12-31 |
Bill Breitenbach
PRN | Corporate Officer/Principal | - | 21-05-31 |
Dae-Shick Oh
AUD | Comptroller/Controller/Auditor | 69 | 19-03-28 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Mitchell Steiner
BRD | Director/Board Member | 63 | - |
Dong-Hyun Park
FOU | Founder | 67 | 02-09-24 |
James Yeager
CTO | Chief Tech/Sci/R&D Officer | 78 | 04-12-31 |
Peter J. Manso
BRD | Director/Board Member | 70 | - |
Jae-Seung Baek
BRD | Director/Board Member | 71 | 16-03-17 |
Bon-Gwon Gu
BRD | Director/Board Member | 57 | - |
Jeong-Seok Chae
BRD | Director/Board Member | 68 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 29,792,127 | 21,294,194 ( 71.48 %) | 0 | 71.48 % |
Company contact information
Mezzion Pharma Co., Ltd.
7th Floor, Seokcheon Building 570, Samseong-ro
06163, Seoul
+
http://www.mezzion.co.kr![address Mezzion Pharma Co.,Ltd.(A140410)](https://cdn.zonebourse.com/static/address/14028296.png)
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
-4.87% | 799M | |
+4.86% | 71.18B | |
+30.17% | 9.61B | |
+27.03% | 4.73B | |
-20.42% | 4.53B | |
+17.61% | 3.68B | |
+8.68% | 1.96B | |
-0.34% | 2.03B | |
-38.87% | 1.81B | |
-45.08% | 1.71B |
- Stock Market
- Equities
- A140410 Stock
- Company Mezzion Pharma Co.,Ltd.